Stocks
Heron Therapeutics (HRTX) P/FCF US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -14.6 | -10.0 | -4.36 | -1.83 | -3.89 | -10.7 | |||
| Changes by years, y/y, % | +54% | -31% | -57% | -58% | +113% | -16.3% | |||
Heron Therapeutics. P/FCF
Heron Therapeutics. P/FCF, changes, %
Heron Therapeutics (HRTX) P/FCF US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/FCF | -1.49 | -4.23 | -9.36 | -23.7 | -31.6 | -10.7 | ||
| Changes by years, y/y, % | -51% | +111% | +570% | +2 075% | +2 029% | |||
| Changes by quarters, q/q, % | +37% | +185% | +121% | +153% | +34% | |||
